MEDROL (methylprednisolone) improves anti-inflammatory action by 25%, with even less tendency to induce sodium and water retention. With its enhanced potency, lower doses of MEDROL achieve results similar to prednisone and prednisolone, but reduce the risk of side effects.
|
Features:
MEDROL fast Action achieves peak serum levels in 1 hour to 2 hours, to relieve itching quickly. MEDROL is safe and Effective offers the same itch relief as prednisolone, but with less potential for side effects. Small, easy-to-swallow tablets are cross-scored for easy dose adjustment. Each 4-mg tablet contains 4 mg methylprednisolone.
Technical Specs:
- MEDROL Indications:Dermal conditions, such as non-specific eczema, summer dermatitis and burns. Allergic manifestations, such as acute urticaria, allergic dermatitis, drug and serum reactions, bronchial asthma, and pollen sensitivities. Ocular conditions, such as iritis, iridocyclitis, secondary glaucoma, uveitis and chorioretinitis. Otic conditions, such as otitis externa. Musculoskeletal conditions, such as myositis, rheumatoid arthritis, osteoarthritis, and bursitis. Various chronic or recurrent diseases of unknown etiology, such as ulcerative colitis and nephrosis.
Manufacturer/Label Information:
Methylprednisolone, a potent anti-inflammatory steroid synthesized and developed in the Research Laboratories of The Upjohn Company is the 6-methyl derivative of prednisolone. It has a greater anti-inflammatory potency than prednisolone and even less tendency than prednisolone to induce sodium and water retention. Its advantage over the older corticoids lies in its ability to achieve equal anti-inflammatory effect with lower dose, while at the same time enhancing the split between anti-inflammatory and mineral corticoid activities.
|
|
